Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 11, 1999, Pages 2813-2816

  Wichelhaus, Thomas A ^a   Schäfer, Volker ^a   Brade, Volker ^a   Böddinghaus, Boris ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DNA; RIFABUTIN; RIFAMPICIN; RIFAPENTINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CROSS RESISTANCE; DNA SEQUENCE; GENE MUTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS;

EID: 0344604266     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.11.2813     Document Type: Article

References (27)

1. Aboshkiwa, M., G. Rowland, and G. Coleman. 1995. Nucleotide sequence of the Staphylococcus aureus RNA polymerase rpoB gene and comparison of its predicted amino acid sequence with those of other bacteria. Biochim. Biophys. Acta 1262:73-78.
2. Aubry-Damon, H., C. J. Soussy, and P. Courvalin. 1998. Characterization of mutants in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 42:2590-2594.
3. Bodmer, T., G. Zürcher, P. Imboden, and A. Telenti. 1995. Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 35:345-348.
4. Carter, P. E., F. J. R. Abadi, D. E. Yakubu, and T. H. Pennington. 1994. Molecular characterization of rifampicin-resistant Neisseria meningitidis. Antimicrob. Agents Chemother. 38:1256-1261.
5. Chambers, H. F. 1997. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10:781-791.
6. Fujii, K., A. Tsuji, S. Miyazaki, K. Yamaguchi, and S. Goto. 1994. In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives. Antimicrob. Agents Chemother. 38:1118-1122.
7. Honore, N., and S. T. Cole. 1993. Molecular basis of rifampin resistance in Mycobacterium leprae. Antimicrob. Agents Chemother. 37:414-418.
8. Jin, D. J., and C. A. Gross. 1988. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202:45-58.
9. Kunin, C. M. 1996. Antimicrobial activity of rifabutin. Clin. Infect. Dis. 22:S3-S14.
10. Michel, M., and L. Gutmann. 1997. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet 349:1901-1906.
11. Miller, L. P., J. T. Crawford, and T. M. Shinnick. 1994. The rpoB gene of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:805-811.
12. Morrow, T. O., and S. A. Harmon. 1979. Genetic analysis of Staphylococcus aureus RNA polymerase mutants. J. Bacteriol. 137:374-383.
13. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Ovchinnikov, Y. A., G. S. Monastyrskaya, V. V. Gubanov, S. O. Guryev, O. Y. Chertov, N. N. Modyanov, V. A. Grinkevich, I. A. Makarova, T. V. Marchenko, I. N. Polovnikova, V. M. Lipkin, and E. D. Sverdlov. 1981. The primary structure of Escherichia coli RNA polymerase. Eur. J. Biochem. 116:621-629.
15. Rahman, M. 1998. Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections. J. Antimicrob. Chemother. 41:325-328.
16. Schmitz, F. J., and M. E. Jones. 1997. Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices? Int. J. Antimicrob. Agents 9:1-19.
17. Severlnov, K., A. Mustaev, E. Severinova, M. Kozlov, S. A. Darst, and A. Goldfarb. 1995. The β-subunit rif-cluster I is only angstroms away from the active center of Escherichia coli RNA polymerase. J. Biol. Chem. 270:29428-29432.
18. Severinov, K., M. Soushko, A. Goldfarb, and V. Nikiforov. 1993. Rifampicin region revisited. J. Biol. Chem. 268:14820-14825.
19. Severinov, K., M. Soushko, A. Goldfarb, and V. Nikiforov. 1994. RifR mutations in the beginning of the Escherichia coli rpoB gene. Mol. Gen. Genet. 244:120-126.
20. Taniguchi, H., H. Aramaki, Y. Nikaldo, Y. Mizuguchi, M. Nakamura, T. Koga, and S. Yoshida. 1996. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol. Lett. 144:103-108.
21. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
22. Voss, A., D. Milatovic, C. Wallrauch-Schwarz, V. T. Rosdahl, and I. Braveny. 1994. Methicillin-resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 13:50-55.
23. Wehrli, W. 1983. Rifampin: mechanisms of action and resistance. Rev. Infect. Dis. 5:S407-S411.
24. Wichelhaus, T. A., J. Schulze, K. P. Hunfeld, V. Schäfer, and V. Brade. 1997. Clonal heterogeneity, distribution, and pathogenicity of methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 16:893-897.
25. Williams, D. L., L. Spring, L. Collins, L. P. Miller, L. B. Heifets, P. R. J. Gangadharam, and T. P. Gillis. 1998. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:1853-1857.
26. Yang, B., H. Koga, H. Ohno, K. Ogawa, M. Fukuda, Y. Hirakata, S. Maesaki, K. Tomono, T. Tashiro, and S. Kohno. 1998. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 42:621-628.
27. Yao, J. D. C., and R. C. Moellering. 1995. Antibacterial agents, p. 1281-1307. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.